Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia. Leuk Res 2022 Dec;123:106984

Date

11/20/2022

Pubmed ID

36401944

DOI

10.1016/j.leukres.2022.106984

Scopus ID

2-s2.0-85141943453 (requires institutional sign-in at Scopus site)   3 Citations

Author List

Abedin SM, Badar T, Gauger K, Michaelis LC, Runaas L, Carlson KS, Murthy GG, Atallah E

Authors

Sameem Abedin MD Associate Professor in the Medicine department at Medical College of Wisconsin
Ehab L. Atallah MD Professor in the Medicine department at Medical College of Wisconsin
Karen-Sue B. Carlson MD, PhD Associate Professor in the Medicine department at Medical College of Wisconsin
Laura Michaelis MD Chief, Professor in the Medicine department at Medical College of Wisconsin
Lyndsey Runaas MD Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Benzimidazoles
Humans
Leukemia, Myeloid, Acute